Vall d'Hebron Talks by VHIR 'From target discovery to preclinical development of a first-in-class Hedgehog pathway inhibitor for rhabdomyosarcoma'

 Vall d'Hebron Talks by VHIR
  Boardroom of the VHIR Edifici Central (Floor 0) — See in map
17/12/2025
17/12/2025 -- From 12:00h to 13:00h
Organize :
Vall d'Hebron Institut de Recerca (VHIR)
Modality: In-person
Share it:

Speaker: Dr. Patricia Zarzosa Martínez, is a postdoctoral researcher in the Sarcoma Laboratory of the Childhood Cancer and Blood Disorders Group, Vall d’Hebron Research Institute (VHIR).

Abstract:
Targeted therapies are transforming cancer treatment by improving patient outcomes while minimizing toxicity. However, there is an especially critical therapeutic gap in pediatric oncology, where effective targeted treatments are urgently needed. Pediatric soft-tissue sarcomas still rely heavily on genotoxic chemotherapy, which causes severe long-term side effects and offers limited benefit for patients with aggressive or relapsed disease.

Host: Dr. Josep Roma Castanyer, Main researcher Childhood Cancer and Blood Disorders. Vall d’Hebron Research Institute (VHIR).  

Subscribe to our newsletters and be a part of Campus Life

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”.
Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health).
Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information.
Legal basis: Consent of the data subject.
Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen.
Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time.
Source: The data subject.
Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.